title: [Clinical efficacy of radiotherapy and chemotherapy combined with surgical treatment for the patients with primay mediastinal B-cell lymphoma].
abstract: OBJECTIVE
  This study was to investigate the clinical efficacy of radiotherapy and chemotherapy combined with surgical treatment for treatment of patients with primay mediastinal B-cell lymphoma.
  
  
  METHODS
  A total of 62 patients with primay mediastinal B-cell lymphoma was selected, out of them 26 patients received radiotherapy and che-motherapy were selected as A group, other 36 patients received radiotherapy and chemotherapy combined with surgical treatment and were selected as B group. Clinical efficacy were observed and compared after treatment.
  
  
  RESULTS
  In A group 5 patients achieved complete remission (CR), 5 patients achieved partial remission (PR), the total remission rate of A group was 27.8%; in B grouop, 13 patients achieved complete remission (CR), 10 patients achieved PR, the total remission rate of B group was 63.9%. The average survival time of patients in B group was 57.244 months, and the average survival time of patients in A group was 55.541 months, the former was higher than latter. The 5 years survical rate of patients in A group was 57.7%, and the 5 years survival rate of patients in B group was 80.6%, the latter was significantly higher than former.
  
  
  CONCLUSIONS
  Radiotherapy and chemotherapy combined with surgical treatment for patients with primay media-stinal B-cell lymphoma has been confirmed to be effective, and may be used in clinic.
authors: Department of Thoracic Surgery, Nanyang Central Hospital, Nanyang 473000, Henan Province, China. E-mail: 33931462@qq.com.
authors: Peng-Fei
authors: PF
authors: Su
mesh_terms: D000970:Antineoplastic Agents; D059248:Chemoradiotherapy; D006801:Humans; D016393:Lymphoma, B-Cell; D012074:Remission Induction; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents